Cardiac glycosides inhibit early and late vaccinia virus protein expression
Journal of General Virology · 2024
DOI: 10.1099/jgv.0.001971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Virology, 2024. Verfasst von Jerzy Samolej und 3 weiteren Autor:innen. Beteiligte Einrichtung: Insititute of Microbiology and Infection, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Cardiac Glycosides, Vaccinia, Poxviridae. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Cardiac glycosides (CGs) are natural steroid glycosides, which act as inhibitors of the cellular sodium-potassium ATPase pump. Although traditionally considered toxic to human cells, CGs are widely used as drugs for the treatment of cardiovascular-related medical conditions. More recently, CGs have been explored as potential anti-viral drugs and inhibit replication of a range of RNA and DNA viruses. Previously, a compound screen identified CGs that inhibited vaccinia virus (VACV) infection. However, no further investigation of the inhibitory potential of these compounds was performed, nor was there investigation of the stage(s) of the poxvirus lifecycle they impacted. Here, we investigated the anti-poxvirus activity of a broad panel of CGs. We found that all CGs tested were potent inhibitors of VACV replication. Our virological experiments showed that CGs did not impact virus infectivity, binding, or entry. Rather, experiments using recombinant viruses expressing reporter proteins controlled by VACV promoters and arabinoside release assays demonstrated that CGs inhibited early and late VACV protein expression at different concentrations. Lack of virus assembly in the presence of CGs was confirmed using electron microscopy. Thus, we expand our understanding of compounds with anti-poxvirus activity and highlight a yet unrecognized mechanism by which poxvirus replication can be inhibited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Insititute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
- Laboratory for Molecular Cell Biology, University College London, London, UK.
- Institute for Infection and Immunity, St George's, University of London, London, UK.
Förderung
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Samolej, J., White, I. J., Strang, B. L., & Mercer, J. (2024). Cardiac glycosides inhibit early and late vaccinia virus protein expression. Journal of General Virology. https://doi.org/10.1099/jgv.0.001971
Vancouver
Samolej J, White IJ, Strang BL, Mercer J. Cardiac glycosides inhibit early and late vaccinia virus protein expression. Journal of General Virology. 2024. doi:10.1099/jgv.0.001971
BibTeX
@article{Samolej2024,
author = {Samolej, Jerzy and White, Ian J and Strang, Blair L and Mercer, Jason},
title = {Cardiac glycosides inhibit early and late vaccinia virus protein expression},
journal = {Journal of General Virology},
year = {2024},
doi = {10.1099/jgv.0.001971}
}
EUVIMED